National Survey of Canadian Community Pharmacists
2022 Data Tables
Survey Topics
Data Tables
This data is available in an accessible format on our detailed visualizations. If data is not available for a question you’re interested in, please contact us.
| Questions | Download Excel |
|---|---|
| Q1: Please specify the location of your pharmacy practice | Download |
| Q2: Please specify your main community pharmacy practice setting | Download |
| Q3: Average number of prescriptions (new and refill) dispensed (per day) in your main community pharmacy practice | Download |
| Q4: Thinking about your MAIN pharmacy practice setting, which of these describes the patient record keeping system that you use? | Download |
| Q5: Which of the following do you use in the care of your patients? | |
| Q5r1c1: Electronic reminders for recommended patient care (e.g., follow-up care, monitoring, med reviews) | Download |
| Q5r2c1: Clinical decision support tool (e.g., CPS Drug Information/Full Access (Formerly RxTx), Clinical Practice Guidelines, Rx Files, e-Pocrates, Lexicomp, UpToDate, Others) | Download |
| Q5r3c1: Electronic list of all medications taken by an individual patient (accessible through a provincial/territorial drug information system) | Download |
| Q5r4c1: Electronic warning for adverse drug interactions, adverse drug events and contraindications | Download |
| Q5r5c1: Electronic access to laboratory test results (available through provincial/territorial information systems) | Download |
| Q5r6c1: Electronic transfer of clinical/patient medical information securely to/from other health professionals (by a direct Internet based connection) | Download |
| Q5r7c1: Electronic receipt of prescriptions directly from a prescriber’s EMR via PrescribeIT® (not fax) | Download |
| Q5r8c1: Electronic receipt of prescriptions directly from a prescriber’s EMR via other e-prescribing service (not fax) | Download |
| Q5r9c1: Electronic receipt of prescriptions directly from a prescriber’s EMR via e-fax/autofax | Download |
| Q5r10c1: Electronic two-way communication with prescribers | Download |
| Q6p1 : What is your level of satisfaction with the following aspects of your dispensing-related workflow? | Download |
| Q6p1r1: Time required to enter/transcribe prescription details into the pharmacy management system | Download |
| Q6p1r2: Ability to monitor patient compliance and medication adherence | Download |
| Q6p1r3: Legibility of prescriptions received | Download |
| Q6p1r4: Prescriber selection of correct drug, dose and duration | Download |
| Q6p1r5: Time required to validate the authenticity of a prescription | Download |
| Q6p1r6: Instructions/directions as entered by prescribers | Download |
| Q6p1r7: Drug therapy monitoring and/or medication management specific to opioids and other controlled substances | Download |
| Q6p1r8: Completeness of indications as entered by prescribers | Download |
| Q6p1r9: Time required to communicate with prescribers using telephone | Download |
| Q6p1r10: Time required to communicate with prescribers using fax | Download |
| Q6p1r11: Inter-professional collaboration | Download |
| Q6p1r12: Drug therapy monitoring and/or medication management | Download |
| Q6p1r13: Prescriber identification of potential drug-related problems (e.g., drug-drug interaction, allergy, duplicate drug) | Download |
| Q6p1r14: Issues related to drug coverage (e.g., public formulary, third-party insurance) | Download |
| Q6p1r15: Efficiency in initiating and processing a prescription renewal request | Download |
| Q6p1r16: Distribution of the volume of prescriptions to be processed throughout the work day | Download |
| Q7: If an efficient e-prescribing system were available, would it save you time on the following tasks during a typical workday? | |
| Q7p1r1: Time required to enter / transcribe prescription details into the pharmacy management system | Download |
| Q7p1r2: Ability to monitor patient compliance and medication adherence | Download |
| Q7p1r3: Legibility of prescriptions received | Download |
| Q7p1r4: Prescriber selection of correct drug, dose and duration | Download |
| Q7p1r5: Time required to validate the authenticity of a prescription | Download |
| Q7p1r6: Instructions / directions as entered by prescribers | Download |
| Q7p1r7: Drug therapy monitoring and/or medication management specific to opioids and other controlled substances | Download |
| Q7p1r8: Completeness of indications as entered by prescribers | Download |
| Q7p1r9: Time required to communicate with prescribers using telephone | Download |
| Q7p1r10: Time required to communicate with prescribers using fax | Download |
| Q7p1r11: Inter-professional collaboration | Download |
| Q7p1r12: Drug therapy monitoring and/or medication management | Download |
| Q7p1r13: Prescriber identification of potential drug-related problems (e.g., drug-drug interaction, allergy, duplicate drug) | Download |
| Q7p1r14: Issues related to drug coverage (e.g., public formulary, third-party insurance) | Download |
| Q7p1r15: Efficiency in initiating and processing a prescription renewal request | Download |
| Q7p1r16: Distribution of the volume of prescriptions to be processed throughout the work day | Download |
| Q8: Please estimate the percentage of total weekly prescriptions received in your pharmacy practice from the sources listed below | Download |
| Q8p2r1: Telephone (e.g., physician / prescriber calls) | Download |
| Q8p2r2: Handwritten and brought in by patient | Download |
| Q8p2r3: Handwritten and faxed to pharmacy | Download |
| Q8p2r4: EMR/Computer-generated and faxed to pharmacy fax machine | Download |
| Q8p2r5: EMR/Computer-generated and faxed directly into pharmacy system | Download |
| Q8p2r6: EMR/Computer-generated printout (brought in by patient) | Download |
| Q8p2r7: e-Prescribing via PrescribeIT® | Download |
| Q8p2r8: e-Prescribing (other)(transmitted directly to your pharmacy system from a prescriber’s EMR (not auto-fax or PrescribeIT®) | Download |
| Q8p2r9: Accessed through an electronic provincial drug information system (DIS) | Download |
| Q8r98: Other (please specify): Text field | Download |
| Q9: Please check off the statements that apply for prescriptions via an e-prescribing service such as PrescribeIT | Download |
| Q10: Please select the three most important factors that would influence your use if an electronic prescribing service was available to your pharmacy | Download |
| Q12: If the majority of prescriptions were to be delivered via e-prescribing such as with PrescribeIT®, how would that impact medication errors? | Download |
| Q13: If the majority of prescriptions were to be delivered via e-prescribing such as with PrescribeIT®, how would that impact your pharmacy’s productivity? | Download |
| Q14: As technology continues to advance in pharmacy practice, please rate the importance of the following digitally enabled functionalities to improve the quality of care you provide | Download |
| Q14r1: E-Prescribing (such as with PrescribeIT® is the secure electronic creation and transmission of a prescription between an authorized prescriber and a patient’s pharmacy of choice) | Download |
| Q14r2: Electronic two-way communication with prescribers | Download |
| Q14r3: Integrated decision support tools in the pharmacy practice management system | Download |
| Q14r4: Narcotics monitoring system | Download |
| Q14r5: Access to provincial/territorial electronic health records (complete patient information such as lab results, DI reports, allergies, clinical notes, medication profile, etc.) | Download |
| Q15: Please indicate your level of agreement or disagreement with each of the following statements below | Download |
| Q15r1: Digital solutions such as e-prescribing improve patient care | Download |
| Q15r2: E-prescribing is a priority area for my pharmacy practice | Download |
| Q15r3: E-prescribing will help reduce inappropriate use or diversion of opioids and other controlled substances | Download |
| Q15r4: Electronic two-way communication with prescribers avoids duplication of efforts | Download |
| Q15r5: Electronic two-way communication with prescribers improves the quality of patient consultations/patient care | Download |
| Q15r6: Medication adherence is a concern that e-prescribing can address effectively | Download |
| Q15r7: E-prescribing is a digital solution that should be supported by my pharmacy association and/or pharmacy college | Download |
| Q15r8: My patients want more virtual care options such as e-prescriptions, electronic reminders, and medication lists | Download |
| Q15r9: I have access to the clinical information I need about my patients to provide care | Download |
| Q15r10: I often need to request important clinical information from other care settings about my patients to provide care | Download |
| Q16: Please indicate your preferred time frame for implementing the following initiatives | |
| Q16r1: My pharmacy to be able to send or receive prescriptions electronically | Download |
| Q16r2: All prescriptions to be sent or received electronically in my province/territory | Download |
| Q16r3: All controlled substance (e.g., narcotics, opioids, etc.) prescriptions to be sent or received electronically in my province/territory | Download |
| Q18: Please specify your primary role (i.e. title) within your main community pharmacy practice | Download |
| Q19: Please specify your experience in community pharmacy practice | Download |
| Q20: Please specify your current level of employment in your community pharmacy practice | Download |
| Q21: Which of the following best describes the community where you practise? | Download |
| Q22: Which age category do you belong to? | Download |
| Q23: Gender | Download |